What we do Hikal Ltd is a global partner specializing in pharmaceuticals, crop protection, animal health, biocides, and specialty chemicals manufacturing and research services. |
Founded in 1,988 |
Market share Recognized export house with strong presence in USA, Europe, Japan, and Southeast Asia; notable for API and crop protection industries. |
Problem solved Delivers critical chemical intermediates and APIs to advance healthcare and agriculture, addressing global supply and quality challenges. |
Top clients or who we serve Serves global pharma, agrochemical, animal health companies; operates across B2B segments with multinational contracts. |
Key management - |
Our journey and innovations Founded in 1988, expanded manufacturing from Mahad to Panoli and Bengaluru; achieved multiple USFDA approvals; launched specialty chemicals portfolio and animal health products. |
Where we operate Manufacturing in India; customers across North America, Europe, Japan, Southeast Asia, Latin America, and rest of world. |
Top products or what we offer Manufactures active pharmaceutical ingredients, crop protection chemicals, specialty chemicals, and contract research services. |
Top brands HiZenn (Personal Care), HiFend (Biocides); strong portfolio in APIs and agrochemical intermediates. |
Raw materials needed Specialty chemicals and chemical intermediates sourced for advanced pharma and crop protection manufacturing. |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue mix of recurring contracts and cyclical product sales with growing CDMO (contract development and manufacturing) contributions. |
Our industry position One of India's preferred fine chemical companies with USFDA approvals and global export house status. |
Financial highlights FY25 revenue Rs 1864.8 crore, PAT Rs 90.8 crore; steady growth in pharma and crop protection segments; EBITDA margin improved by 281 bps to 18%. |
Geographical revenue split Revenue from India Rs 704.1 Cr, Europe Rs 530 Cr, USA & Canada Rs 250.6 Cr, Southeast Asia Rs 299 Cr, others Rs 76.1 Cr. |
Order book - |
Whats driving growth Growth driven by pharmaceutical product launches, animal health projects, innovation in specialty chemicals, and strong global CDMO demand. |
Our future plans Expansion in animal health facilities, specialty chemicals portfolio growth, and increased capacity for new pharma and crop protection products. |
Our green promise Implements sustainability initiatives including co-generation plants, biomass boilers, and strong EHS safety culture across sites. |
Our people and values Emphasizes employee skill development, inclusion, and values with over 3100 employees and focus on safety and engagement. |
Key challenges ahead Managing regulatory compliance, global pricing pressures, and competition in a dynamic agrochemical and pharmaceutical market. |
Interesting facts Awarded '5 star Safety Award' by British Safety Council; long-term partnerships with global life sciences companies. |
Risks and strategy Addresses risks through robust quality systems, risk management committees, and diversified product portfolio. |
